Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis
Clinical trial NCT00613171 · COMPLETED
Trial details
- NCT number
- NCT00613171
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-02
- Primary completion
- 2010-01-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.